Gene · 382
Papers3,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,632
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel homeostatic mechanism tunes PI(4,5)P2-dependent signaling at the plasma membrane. | J Cell Sci | 2023 | 37534432 | PubTator, text mining | PubMed |
| Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model. | Sci Rep | 2023 | 37528206 | PubTator, text mining | PubMed |
| Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. | Technol Cancer Res Treat | 2023 | 37525872 | PubTator, text mining | PubMed |
| Vesicle-mediated transport of ALIX and ESCRT-III to the intercellular bridge during cytokinesis. | Cell Mol Life Sci | 2023 | 37523003 | PubTator, text mining | PubMed |
| CSK-mediated signalling by integrins in cancer. | Front Cell Dev Biol | 2023 | 37519303 | PubTator, text mining | PubMed |
| Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane. | Pharmaceutics | 2023 | 37514003 | PubTator, text mining | PubMed |
| Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147. | Biomedicines | 2023 | 37509657 | PubTator, text mining | PubMed |
| Therapeutic Potential of EVs: Targeting Cardiovascular Diseases. | Biomedicines | 2023 | 37509546 | PubTator, text mining | PubMed |
| Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis. | Oncogene | 2023 | 37500798 | PubTator, text mining | PubMed |
| Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review. | Heliyon | 2023 | 37496898 | PubTator, text mining | PubMed |
| A reactive oxygen species-related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma. | Front Oncol | 2023 | 37496661 | PubTator, text mining | PubMed |
| Annexin A2: the missing piece in the puzzle of pathogen-induced damage. | Virulence | 2023 | 37482693 | PubTator, text mining | PubMed |
| The 27th Scientific Conference of the Society on NeuroImmune Pharmacology: New Delhi, India, March 15-18, 2023. | NeuroImmune Pharm Ther | 2023 | 37476290 | PubTator, text mining | PubMed |
| Extracellular vesicles: a rising star for therapeutics and drug delivery. | J Nanobiotechnology | 2023 | 37475025 | PubTator, text mining | PubMed |
| Identification and validation of six acute myocardial infarction-associated variants, including a novel prognostic marker for cardiac mortality. | Front Cardiovasc Med | 2023 | 37465449 | PubTator, text mining | PubMed |
| ARF6 plays a general role in targeting palmitoylated proteins from the Golgi to the plasma membrane. | J Cell Sci | 2023 | 37461827 | Swiss-Prot, curated | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| Evidence for a clathrin-independent endocytic pathway for APP internalization in the neuronal somatodendritic compartment. | Cell Rep | 2023 | 37450368 | PubTator, text mining | PubMed |
| Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer. | Medicine (Baltimore) | 2023 | 37443486 | PubTator, text mining | PubMed |
| An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer. | BMC Cancer | 2023 | 37442985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/382/papers?page=15